Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
PM stresses importance of large-scale, symbolic projects by China in Việt Nam in talks with top Chinese leader 2.